FOR IMMEDIATE RELEASE
Contact:
David W. Moskowitz MD
CEO, GenoMed
Tel. 314.983.9933
dwmoskowitz@genomed.com
Paula M. Hall, LVN
COO, Offshore HRM
Tel. Philippines: 63 918 581 3238
paulamhall@yahoo.com
ST. LOUIS—April 8, 2009—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that it has committed to purchase Offshore HRM, a medical coding company with expertise in setting up call centers in India and the Philippines, for a combination of GenoMed restricted stock and cash.
HRM, or healthcare revenue management, is how doctors’ offices and hospitals are reimbursed by health insurance plans, including Medicare and Medicaid. Doctors and hospitals cannot get paid unless their services are coded properly. Offshore HRM specializes in not missing any opportunities for reimbursement. Training coders takes 3 months.
Offshore HRM recently established a 200-person call center in Bacolod, the Philippines for another client. Offshore HRM will recruit Philippine physicians and nurses and train them in GenoMed’s algorithms so that they can take care of paying patients.
Said Dr. David Moskowitz, GenoMed’s CEO, “GenoMed is engaged in two major activities: managing patients and doing research. Offshore HRM will allow us to manage patients on an enormous scale. They will help us market to patients in the Philippines, a country of 90 million with an extremely high prevalence rate of diabetes. They can also market to physician groups who hire them to do coding, since GenoMed can add further to physicians’ revenues. Offshore HRM will set up protocols for communicating with patients and recording clinical outcomes data in a HIPAA-compliant way. And they will contribute to GenoMed’s revenue stream through their coding activities.”
Paula M. Hall, LVN, Offshore HRM’s COO, said, “We are delighted to become part of a publicly traded company that is the pioneer in delivering low-cost healthcare. Like GenoMed, our mission has been to provide the highest quality work at the lowest possible cost. We pass our savings on to the customer. GenoMed’s Disease Management is a logical extension of what we already do.”
Ms. Hall, a former dialysis nurse, ended by saying, “It is a particular pleasure for me to help Dr. Moskowitz try to make the Philippines dialysis-free. I’ve seen the horrors of dialysis, and I wouldn’t wish it on my worst enemy. I’m thrilled that Dr. Moskowitz has found a simple way to prevent most of it. We look forward to working with him to implement his protocols for patients in the Philippines as well as the rest of the world.”
About Offshore HRM
Offshore HRM is a fully certified trainer of coding for healthcare reimbursement. Physicians and hospitals are encouraged to contact Ms. Hall (see contact information above) for an estimate of how much revenue they could gain by switching to Offshore HRM.
About GenoMed (GenoMed”>http://www.genomed.com)
GenoMed is a Next Generation Disease Management company that aims to deliver the best patient outcomes at the lowest possible cost. GenoMed wants to prove that it can arrest diabetes, hypertension, and emphysema even in a developing country with scant resources like the Philippines. GenoMed intends to be the global healthcare provider of choice, especially for America’s 50 million uninsured.
Safe Harbor Statement
This press release contains forward looking statements, including those statements pertaining to GenoMed, Inc.’s (the Company’s) finances and treatments. The words or phrases “ought to,” “should,” “could,” “may,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those projected in the forward looking statements as a result of a number of risks and uncertainties, including but not limited to our research and development being subject to scientific, economic, regulatory, governmental, and technological factors. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we specifically disclaim any obligation to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.